Follow
Jules Derks
Jules Derks
Maastricht University Medical Centre
Verified email at maastrichtuniversity.nl
Title
Cited by
Cited by
Year
Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome
JL Derks, N Leblay, E Thunnissen, RJ Van Suylen, M den Bakker, ...
Clinical Cancer Research 24 (1), 33-42, 2018
1922018
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
N Alcala, N Leblay, AAG Gabriel, L Mangiante, D Hervás, T Giffon, ...
Nature communications 10 (1), 3407, 2019
1632019
New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management
JL Derks, N Leblay, S Lantuejoul, AMC Dingemans, EJM Speel, ...
Journal of Thoracic Oncology 13 (6), 752-766, 2018
1302018
Clinical features of large cell neuroendocrine carcinoma: a population-based overview
JL Derks, LE Hendriks, WA Buikhuisen, HJM Groen, E Thunnissen, ...
European Respiratory Journal 47 (2), 615-624, 2016
1272016
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
JL Derks, RJ Van Suylen, E Thunnissen, MA Den Bakker, HJ Groen, ...
European Respiratory Journal 49 (6), 2017
1092017
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: results from a population-based study
LE Hendriks, JL Derks, PE Postmus, RA Damhuis, RMA Houben, ...
European journal of cancer 51 (17), 2534-2544, 2015
632015
Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer
C Kuijpers, LEL Hendriks, JL Derks, AMC Dingemans, ASR Van Lindert, ...
Lung Cancer 121, 76-81, 2018
572018
KRAS mutations in advanced nonsquamous non–small-cell lung cancer patients treated with first-line platinum-based chemotherapy have no predictive value
WW Mellema, AMC Dingemans, E Thunnissen, PJF Snijders, J Derks, ...
Journal of thoracic oncology 8 (9), 1190-1195, 2013
522013
DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile
BCM Hermans, JL Derks, E Thunnissen, RJ van Suylen, MA den Bakker, ...
Lung Cancer 138, 102-108, 2019
512019
Clinical-pathologic challenges in the classification of pulmonary neuroendocrine neoplasms and targets on the horizon for future clinical practice
JL Derks, N Rijnsburger, BCM Hermans, L Moonen, LM Hillen, ...
Journal of Thoracic Oncology 16 (10), 1632-1646, 2021
402021
Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
JL Derks, AMC Dingemans, RJ van Suylen, MA den Bakker, ...
Histopathology 74 (4), 555-566, 2019
392019
Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC)
BCM Hermans, JL Derks, E Thunnissen, RJ Van Suylen, MA Den Bakker, ...
Lung Cancer 130, 179-186, 2019
372019
Orthopedia homeobox (OTP) in pulmonary neuroendocrine tumors: the diagnostic value and possible molecular interactions
L Moonen, J Derks, AM Dingemans, EJ Speel
Cancers 11 (10), 1508, 2019
272019
Pulmonary neuroendocrine neoplasms with well differentiated morphology and high proliferative activity: illustrated by a case series and review of the literature
BCM Hermans, JL Derks, L Moonen, CHJ Habraken, J von der Thüsen, ...
Lung Cancer 150, 152-158, 2020
242020
Preoperative biopsy diagnosis in pulmonary carcinoids, a shot in the dark
L Moonen, JL Derks, BCM Hermans, IM Bunnik, LM Hillen, RJ van Suylen, ...
Journal of Thoracic Oncology 16 (4), 610-618, 2021
192021
Unique metastatic patterns in neuroendocrine neoplasms of different primary origin
BCM Hermans, J de Vos-Geelen, JL Derks, L Latten, IH Liem, ...
Neuroendocrinology 111 (11), 1111-1120, 2021
172021
A population-based analysis of application of WHO nomenclature in pathology reports of pulmonary neuroendocrine tumors
JL Derks, RJ van Suylen, E Thunnissen, MA den Bakker, EF Smit, ...
Journal of Thoracic Oncology 11 (4), 593-602, 2016
172016
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
TL Dayton, N Alcala, L Moonen, L den Hartigh, V Geurts, L Mangiante, ...
Cancer Cell 41 (12), 2083-2099. e9, 2023
162023
Neuroendocrine cancer of the lung: a diagnostic puzzle
JL Derks, EJM Speel, E Thunnissen, RJ van Suylen, WA Buikhuisen, ...
Journal of thoracic oncology 11 (3), e35-e38, 2016
142016
Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype
BCM Hermans, JL Derks, HJM Groen, JA Stigt, RJ van Suylen, LM Hillen, ...
Endocrine Connections 8 (12), 1600-1606, 2019
82019
The system can't perform the operation now. Try again later.
Articles 1–20